Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR

A total of 36 consecutive patients with AML in CR underwent reduced-intensity allogeneic hematopoietic SCT (RISCT) with fludarabine and melphalan conditioning. All patients were ineligible for myeloablative transplantation because of age or comorbidity. In total, 30 patients were in first CR and six...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Marrow Transplant
Main Authors: Popat, U, de Lima, MJ, Saliba, RM, Anderlini, P, Andersson, BS, Alousi, AM, Hosing, C, Nieto, Y, Parmar, S, Khouri, IF, Kebriaei, P, Qazilbash, M, Champlin, RE, Giralt, SA
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320641/
https://ncbi.nlm.nih.gov/pubmed/21423123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2011.61
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados